Cargando…
Editorial: Pharmacokinetic evaluation and modeling of clinically significant drug metabolites, Volume II
Autores principales: | Mikov, Momir, Đanić, Maja, Lazarević, Slavica, Pavlović, Nebojša, Stanimirov, Bojan, Al-Salami, Hani, Mooranian, Armin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846551/ https://www.ncbi.nlm.nih.gov/pubmed/36686693 http://dx.doi.org/10.3389/fphar.2022.1087988 |
Ejemplares similares
-
Bioaccumulation and biotransformation of simvastatin in probiotic bacteria: A step towards better understanding of drug-bile acids-microbiome interactions
por: Đanić, Maja, et al.
Publicado: (2023) -
Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease
por: Lazarević, Slavica, et al.
Publicado: (2022) -
Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles
por: Pavlović, Nebojša, et al.
Publicado: (2018) -
Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model
por: Ðanić, Maja, et al.
Publicado: (2019) -
Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
por: Ðanić, Maja, et al.
Publicado: (2018)